Cyclin A and cyclin D1 as significant prognostic markers in colorectal cancer patients

被引:115
作者
Bahnassy, AA [1 ]
Zekri, ARN
El-Houssini, S
El-Shehaby, AMR
Mahmoud, MR
Abdallah, S
El-Serafi, M
机构
[1] Cairo Univ, Natl Canc Inst, Dept Pathol, Cairo, Egypt
[2] Cairo Univ, Natl Canc Inst, Dept Canc Biol, Virol & Immunol Unit, Cairo, Egypt
[3] Cairo Univ, Kasr El Eini Sch Med, Dept Biochem, Cairo, Egypt
[4] Cairo Univ, Kasr El Eini Sch Med, Dept Pathol, Cairo, Egypt
[5] Cairo Univ, Natl Canc Inst, Dept Med Oncol, Cairo, Egypt
关键词
D O I
10.1186/1471-230X-4-22
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
Background: Colorectal cancer is a common cancer all over the world. Aberrations in the cell cycle checkpoints have been shown to be of prognostic significance in colorectal cancer. Methods: The expression of cyclin D1, cyclin A, histone H3 and Ki-67 was examined in 60 colorectal cancer cases for co-regulation and impact on overall survival using immunohistochemistry, southern blot and in situ hybridization techniques. Immunoreactivity was evaluated semi quantitatively by determining the staining index of the studied proteins. Results: There was a significant correlation between cyclin D1 gene amplification and protein overexpression (concordance = 63.6%) and between Ki-67 and the other studied proteins. The staining index for Ki-67, cyclin A and D1 was higher in large, poorly differentiated tumors. The staining index of cyclin D1 was significantly higher in cases with deeply invasive tumors and nodal metastasis. Overexpression of cyclin A and D1 and amplification of cyclin D1 were associated with reduced overall survival. Multivariate analysis shows that cyclin D1 and A are two independent prognostic factors in colorectal cancer patients. Conclusions: Loss of cell cycle checkpoints control is common in colorectal cancer. Cyclin A and D1 are superior independent indicators of poor prognosis in colorectal cancer patients. Therefore, they may help in predicting the clinical outcome of those patients on an individual basis and could be considered important therapeutic targets.
引用
收藏
页数:12
相关论文
共 35 条
  • [1] Increased expression of cyclin D1 is an early event in multistage colorectal carcinogenesis
    Arber, N
    Hibshoosh, H
    Moss, SF
    Sutter, T
    Zhang, Y
    Begg, M
    Wang, SB
    Weinstein, IB
    Holt, PR
    [J]. GASTROENTEROLOGY, 1996, 110 (03) : 669 - 674
  • [2] THE PRAD-1 CYCLIN D1 ONCOGENE PRODUCT ACCUMULATES ABERRANTLY IN A SUBSET OF COLORECTAL CARCINOMAS
    BARTKOVA, J
    LUKAS, J
    STRAUSS, M
    BARTEK, J
    [J]. INTERNATIONAL JOURNAL OF CANCER, 1994, 58 (04) : 568 - 573
  • [3] BUCKLEY MF, 1993, ONCOGENE, V8, P2127
  • [4] CHOU MY, 1990, AM J PATHOL, V136, P729
  • [5] CORDONCARDO C, 1995, AM J PATHOL, V147, P545
  • [6] GILLETT C, 1994, CANCER RES, V54, P1812
  • [7] Validation of the S-phase specificity of histone (H3) in situ hybridization in normal and malignant cells
    Gown, AM
    Jiang, JJ
    Matles, H
    Skelly, M
    Goodpaster, T
    Cass, L
    Reshatof, M
    Spaulding, D
    Coltrera, MD
    [J]. JOURNAL OF HISTOCHEMISTRY & CYTOCHEMISTRY, 1996, 44 (03) : 221 - 226
  • [8] Ulcerative colitis and colorectal carcinoma -: DNA-profile, laminin-5 γ2 chain and cyclin A expression as early markers for risk assessment
    Habermann, J
    Lenander, C
    Roblick, UJ
    Krüger, S
    Ludwig, D
    Alaiya, A
    Freitag, S
    Dümbgen, L
    Bruch, HP
    Stange, E
    Salo, S
    Tryggvason, K
    Auer, G
    Schimmelpenning, H
    [J]. SCANDINAVIAN JOURNAL OF GASTROENTEROLOGY, 2001, 36 (07) : 751 - 758
  • [9] Handa K, 1999, INT J CANCER, V84, P225, DOI 10.1002/(SICI)1097-0215(19990621)84:3<225::AID-IJC5>3.3.CO
  • [10] 2-1